Equitec Proprietary Markets’s Repare Therapeutics RPTX Stock Holding History

Equitec Proprietary Markets’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-118,375	Closed	-$308K	–	106
2025 Q4	$308K	Buy	+118,375	New	+$238K	0.18%	33

Equitec Proprietary Markets's RPTX Position: Q1 2026 in Review

Equitec Proprietary Markets sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 118,375 shares — an estimated $308K sold.

Equitec Proprietary Markets first reported a position in RPTX in Q4 2025 and held it in 1 quarter. The position peaked at $308K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Equitec Proprietary Markets reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Equitec Proprietary Markets sold 118,375 Repare Therapeutics shares in Q1 2026, an estimated $308K.
Equitec Proprietary Markets first reported a position in Repare Therapeutics in Q4 2025 and held it in 1 quarter.
Equitec Proprietary Markets's Repare Therapeutics position peaked at $308K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Equitec Proprietary Markets's 13F filing for Q1 2026, filed 11 May 2026.